Table 1.
Meta-analysis | No of studies | Effect size (95% CI) | I2 (%) |
---|---|---|---|
Agomelatine v placebo | |||
Fixed effect model using final scores | 12 | 0.23 (0.17 to 0.30) | 66 |
Random effects model using changes scores | 12 | 0.23 (0.12 to 0.34) | 66 |
Random effects model using ANCOVA estimates (HAM-D scores only) | 10 | 1.9 (0.94 to 2.87)* | 68 |
Random effects model using raw HAM-D final scores | 11 | 1.97 (1.12 to 2.82)† | 60 |
Agomelatine v other antidepressant | |||
Fixed effect model using final scores | 13 | 1.00 (−0.06 to 0.06) | 59 |
Random effects model using changes scores | 13 | −0.01 (−0.10 to 0.10) | 56 |
Random effects model using raw HAM-D final scores | 12 | 0.06 (−0.40 to 0.53)† | 63 |
*Raw mean differences on HAM-D scale adjusted for baseline scores.
†Raw mean differences on HAM-D scale.